Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ISRCTN33418225) titled 'Increasing informed participation in lung cancer screening using pathway navigation' on May 1.
Study Type: Interventional
Study Design:
Multi-centre randomized controlled trial using a type one hybrid effectiveness-implementation design (Screening)
Primary Sponsor: North Bristol NHS Trust
Condition:
Lung cancer screening
Cancer
Intervention:
This is a multi-centre randomised controlled trial study with decentralised/remote follow-up, assessing the impact of a pathway navigator on participation in lung cancer screening (within the Lung Cancer Screening (LCS) programme). A navigator is a trained healthcare pr...